The company said net sales for Q1 2025 (3 months) rose 2.6% year over year to $2,070 million from $2,016 million, and organic sales grew 4.3%.

1. 01

   The company said net sales for Q1 2025 (3 months) rose 2.6% year over year to $2,070 million from $2,016 million, and organic sales grew 4.3%.

2. 02

   Solventum said its operating income margin for Q1 2025 was 7.3% (18.9% a year earlier) and its adjusted operating income margin was 19.7% (24.0% a year earlier). It cited lower gross margins and higher operating expenses from public company stand-up costs and growth investments as factors.

3. 03

   Solventum reported net income of $137 million for Q1 2025 ($237 million a year earlier), GAAP diluted earnings per share of $0.78, and adjusted diluted earnings per share of $1.34 ($2.08 a year earlier).

4. 04

   The company said net cash provided by operating activities was $29 million for Q1 2025 ($442 million a year earlier), and free cash flow was $(80) million ($340 million a year earlier). It said free cash flow is operating cash flow less purchases of property, plant and equipment.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.